Department of Gastrointestinal Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Ann Surg Oncol. 2022 Jun;29(6):3505-3514. doi: 10.1245/s10434-022-11382-x. Epub 2022 Feb 14.
Laparoscopic radical antegrade modular pancreatosplenectomy (Lap-RAMPS) for left-sided pancreatic cancer remains a technically challenging procedure. How to approach the splenic artery in laparoscopic surgery has not been discussed in adequate detail, and the implications of an artery-first approach in left-sided pancreatic cancer remain unclear.
Forty-five consecutive patients with left-sided resectable pancreatic cancer underwent Lap-RAMPS between July 2018 and September 2020. They were divided according to whether Lap-RAMPS was performed using an anterocranial splenic artery-first (ASF) approach (ASF group, n = 23) or via another approach (non-ASF group, n = 22). Clinical, pathological, and short-term outcomes were reviewed and compared between the groups.
The ASF approach was performed safely in all patients with resectable left-sided pancreatic cancer, and none required conversion to laparotomy. The ASF group had better outcomes in terms of conspicuous bleeding from the spleen during splenic mobilization (P = 0.016) and blood pooling during posterior dissection (P = 0.035). Consequently, blood loss was significantly less and operation time was significantly shorter in the ASF group than in the non-ASF group. There was no significant between-group difference in other short-term outcomes, including mortality, length of hospital stay, or Clavien-Dindo classification.
The ASF approach was safe when performed for resectable left-sided pancreatic cancer and may help to prevent congestion of the pancreas and lessen intraoperative blood loss.
腹腔镜根治性顺行模块胰脾切除术(Lap-RAMPS)治疗左侧胰腺癌仍然是一项具有挑战性的技术操作。在腹腔镜手术中如何处理脾动脉尚未得到充分讨论,左侧胰腺癌中动脉优先入路的意义仍不清楚。
2018 年 7 月至 2020 年 9 月,连续 45 例左侧可切除胰腺癌患者接受 Lap-RAMPS 治疗。根据是否采用经颅前脾动脉优先(ASF)入路(ASF 组,n = 23)或其他入路(非 ASF 组,n = 22)进行 Lap-RAMPS ,将患者分为两组。回顾并比较两组患者的临床、病理和短期预后。
所有可切除左侧胰腺癌患者均安全地完成了 ASF 入路,无一例需要转为开腹手术。ASF 组在脾血管游离时明显脾脏出血(P = 0.016)和后向分离时血液积聚(P = 0.035)方面的结果更好。因此,ASF 组的出血量明显少于非 ASF 组,手术时间也明显短于非 ASF 组。两组在其他短期预后方面,包括死亡率、住院时间或 Clavien-Dindo 分级,均无显著差异。
对于可切除的左侧胰腺癌,ASF 入路是安全的,可能有助于预防胰腺充血和减少术中出血量。